Cortexyme Announces Preclinical Data Showing Benefits of Atuzaginstat
09 Mar 2022 //
BUSINESSWIRE
Cortexyme to focus on 2nd Alzheimer`s bet after clinical hold
27 Jan 2022 //
FIERCEBIOTECH
Cortexyme picks a lower dose for nebulous Alzheimer`s drug
13 Nov 2021 //
BIOPHARMADIVE
Cortexyme will forge ahead with failed Alzheimer`s drug
27 Oct 2021 //
STATNEWS
Cortexyme Expands Pipeline with Initiation of Phase 1 Trial of COR588
08 Sep 2021 //
BUSINESSWIRE